Medical device company STERIBITE LLC reported on Tuesday the receipt of US FDA 510(k) clearance to market its first patented Steribite Disposable Kerrison Rongeur for the removal of bones on all spine procedures.
The company said the Kerrison rongeurs are instruments used to remove bone on all spine procedures and are critical in one of the stages of the operation; however reusable Kerrison rongeurs are difficult to clean, raising the risk of possible infection to the patients.
In addition, the reusable Kerrison rongeurs are expensive and difficult to maintain, which is frustrating for spine surgeons and increases the risk for patients.
STERIBITE LLC is a privately held medical device company and was developed by RJR Surgical Inc, a Cleveland, Ohio based company.
AbbVie's ELAHERE receives full US FDA approval
Johnson & Johnson's OPSYNVI receives US FDA approval
Outlook Therapeutics receives positive CHMP opinion for ONS-5010 in wet AMD treatment
Human Immunology Biosciences receives ODD from FDA for felzartamab
Eton Pharmaceuticals acquires PKU GOLIKE, expanding rare disease portfolio
Vertex receives FDA clearance for VX-407 Investigational New Drug Application for ADPKD
Phanes Therapeutics receives FDA Fast Track designation for PT886
Bio-Thera Solutions signs new licensing agreement with SteinCares
FDA accepts resubmission of Citius Pharmaceuticals, Inc's BLA for LYMPHIR
GSK Plc reports positive Phase III Jemperli data for endometrial cancer
ImmVira receives FDA Fast Track designation for MVR-T3011 IT